Vonoprazan is Efficacious for Treatment of Heartburn in Non-erosive Reflux Disease: A Randomized Trial

Deborah Adekunle, MBChB, MPH

&

Subcutaneous Infliximab (CT-P13 SC) as Maintenance Therapy for Inflammatory Bowel Disease: Two Randomized Phase 3 Trials (LIBERTY)

Brett Riederman, MD

Please Contact Beth Buschard-Steiger (bbuscha@wustl.edu) for Zoom Details